Picture of L&C Bio Co logo

290650 L&C Bio Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-2.63%
3m-29.09%
6m-30.07%
1yr+13.74%
Volume Change (%)
10d/3m-1.1%
Price vs... (%)
52w High-38.61%
50d MA-4.43%
200d MA-20.96%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)29.8
PEG Ratio (f)0.97
EPS Growth (f)44.13%
Dividend Yield (f)0.2%
Valuation (ttm)IndustryMarket
Price to Book Value3.89
Price to Tang. Book3.99
Price to Free Cashflown/a
Price to Sales8.61
EV to EBITDA34.09

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.86%
Return on Equity43.94%
Operating Margin17.12%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueKR₩m21,240.8929,151.6732,972.7745,677.0152,572.4969,70088,70024.04%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+11.72+25.85+49.64+25.06-68.1+202.55+44.13n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of L&C Bio Co EPS forecast chart

Profile Summary

L&C BIO Co., Ltd is a Korea-based Company mainly engaged in the regenerative medicine business. The Company mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The Company also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    August 2nd, 2011
    Public Since
    November 1st, 2018
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    22,684,891

    290650 Share Price Performance

    Upcoming Events for 290650

    Similar to 290650

    Picture of Access Bio logo

    Access Bio

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aligned Genetics logo

    Aligned Genetics

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Asta Co logo

    Asta Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Biodyne Co logo

    Biodyne Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Bistos Co logo

    Bistos Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ